Temozolomide after Radiotherapy for Newly Diagnosed High-grade Glioma and Unfavorable Low-grade Glioma in Children

By Broniscer Alberto   Chintagumpala Murali   Fouladi Maryam   Krasin Matthew   Kocak Mehmet   Bowers Daniel   Iacono Lisa   Merchant Thomas   Stewart Clinton   Houghton Peter   Kun Larry   Ledet Davonna   Gajjar Amar  

Journal of Neuro-Oncology, Vol. 76, Iss. 3, 2006-02 ,pp. : 313-319

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of sunitinib malate in patients with recurrent high-grade glioma

By Neyns B.   Sadones J.   Chaskis C.   Dujardin M.   Everaert H.   Lv S.   Duerinck J.   Tynninen O.   Nupponen N.   Michotte A.   Greve J.  

Journal of Neuro-Oncology, Vol. 103, Iss. 3, 2011-07 ,pp. : 491-501

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy of protracted dose-dense temozolomide in patients with recurrent high-grade glioma

By Abacioglu Ufuk   Caglar Hale   Yumuk Perran   Akgun Zuleyha   Atasoy Beste   Sengoz Meric  

Journal of Neuro-Oncology, Vol. 103, Iss. 3, 2011-07 ,pp. : 585-593

Springer Publishing Company

Access to resources Recommend Favorite

Novel cancer-testis antigen expression on glioma cell lines derived from high-grade glioma patients

By Akiyama Yasuto   Komiyama Masaru   Miyata Haruo   Yagoto Mika   Ashizawa Tadashi   Iizuka Akira   Oshita Chie   Kume Akiko   Nogami Masahiro   Ito Ichiro   Watanabe Reiko   Sugino Takashi   Mitsuya Koichi   Hayashi Nakamasa   Nakasu Yoko   Yamaguchi Ken  

Oncology Reports, Vol. 31, Iss. 4, 2014-04 ,pp. : 1683-1690

Spandidos Publications

Access to resources Recommend Favorite

Rebound tumour progression after the cessation of bevacizumab therapy in patients with recurrent high-grade glioma

By Zuniga Richard   Torcuator Roy   Jain Rajan   Anderson John   Doyle Thomas   Schultz Lonni   Mikkelsen Tom  

Journal of Neuro-Oncology, Vol. 99, Iss. 2, 2010-09 ,pp. : 237-242

Springer Publishing Company

Access to resources Recommend Favorite